Surgical Innovations reports H1 revenue of GBP 6.019 million
For the half year ended Sep 30, Surgical Innovations said adjusted EBITDA was GBP 33,000, gross profit GBP 1.748 million and EBIT GBP -230,000.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
For the half year ended Sep 30, Surgical Innovations said adjusted EBITDA was GBP 33,000, gross profit GBP 1.748 million and EBIT GBP -230,000.